Dr. Reddy's Laboratories Limited
RDY
$13.47
$0.060.45%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 785.88M | 777.57M | 677.71M | 700.19M | 752.83M |
| Total Receivables | 1.13B | 1.14B | 1.09B | 1.11B | 1.06B |
| Inventory | 853.53M | 881.48M | 831.92M | 837.00M | 859.83M |
| Prepaid Expenses | 25.68M | 23.38M | 22.04M | 27.02M | 27.25M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 349.43M | 320.24M | 302.52M | 278.31M | 266.06M |
| Total Current Assets | 3.15B | 3.15B | 2.93B | 2.96B | 2.96B |
|
|
|||||
| Total Current Assets | 3.15B | 3.15B | 2.93B | 2.96B | 2.96B |
| Net Property, Plant & Equipment | 1.26B | 1.20B | 1.14B | 1.09B | 1.03B |
| Long-term Investments | 138.44M | 139.63M | 138.21M | 138.53M | 140.52M |
| Goodwill | 138.44M | 139.63M | 138.21M | 138.53M | 140.52M |
| Total Other Intangibles | 1.14B | 1.11B | 1.13B | 1.09B | 1.10B |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 309.59M | 324.89M | 249.29M | 247.63M | 253.79M |
| Total Assets | 6.10B | 6.06B | 5.77B | 5.62B | 5.56B |
|
|
|||||
| Total Accounts Payable | 453.08M | 436.74M | 234.68M | 420.92M | 427.01M |
| Total Accrued Expenses | 436.50M | 404.27M | 513.35M | 411.10M | 429.12M |
| Short-term Debt | 463.29M | 447.51M | 445.25M | 495.45M | 477.68M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 64.69M | 60.25M | 10.03M | 12.92M | 13.82M |
| Total Finance Division Other Current Liabilities | 281.45M | 313.81M | 322.69M | 201.45M | 195.64M |
| Total Other Current Liabilities | 281.45M | 313.81M | 322.69M | 201.45M | 195.64M |
| Total Current Liabilities | 1.70B | 1.66B | 1.53B | 1.54B | 1.54B |
|
|
|||||
| Total Current Liabilities | 1.70B | 1.66B | 1.53B | 1.54B | 1.54B |
| Long-Term Debt | -- | -- | 44.47M | 44.40M | 45.36M |
| Short-term Debt | 463.29M | 447.51M | 445.25M | 495.45M | 477.68M |
| Capital Leases | 131.00M | 59.42M | 47.56M | 44.16M | 42.50M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 195.41M | 210.98M | 205.59M | 233.29M | 238.86M |
| Total Liabilities | 2.03B | 1.93B | 1.82B | 1.86B | 1.87B |
|
|
|||||
| Common Stock & APIC | 136.72M | 141.16M | 140.05M | 139.55M | 142.02M |
| Retained Earnings | 3.80B | 3.85B | 3.70B | 3.50B | 3.41B |
| Treasury Stock & Other | 97.50M | 93.06M | 65.87M | 69.22M | 92.19M |
| Total Common Equity | 4.04B | 4.08B | 3.90B | 3.71B | 3.64B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.04B | 4.08B | 3.90B | 3.71B | 3.64B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 40.45M | 43.09M | 44.21M | 44.92M | 47.01M |
| Total Equity | 4.08B | 4.12B | 3.95B | 3.76B | 3.69B |
|
|
|||||